Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 5/2019

Open Access 01-11-2019 | Fertility | Gynecologic Oncology

Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow-up

Authors: Ariadne L’Heveder, Benjamin P. Jones, Srdjan Saso, Jen Barcroft, Robert Richardson, Baljeet Kaur, Sadaf Ghaem-Maghami, Joseph Yazbek, J. Richard Smith

Published in: Archives of Gynecology and Obstetrics | Issue 5/2019

Login to get access

Abstract

Purpose

Uterine adenosarcomas (UAs) account for 5–8% of cases of uterine sarcomas. Treatment includes total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO).
Fertility preservation is an emerging concept in gynaecology oncology and is particularly relevant in UA, where cases are diagnosed as young as 15-year-old. This manuscript demonstrates a case of UA which was treated conservatively, achieved successful livebirths and underwent completion hysterectomy after two decades of follow-up.

Method

This was a retrospective case note review.

Results

An 18-year-old nulliparous woman presented with abnormal vaginal bleeding. Ultrasound identified an endometrial polyp, which was histologically diagnosed as low-grade adenosarcoma. She was advised to undergo TAH and BSO, but instead decided to preserve her fertility and opted for conservative management. She was monitored with pelvic ultrasound, hysteroscopy and endometrial biopsy bi-annually, with annual pelvic magnetic resonance imaging for 10 years which was uneventful. 11 years post-operatively she conceived following in-vitro fertilization (IVF) but suffered a miscarriage at 16 weeks likely due to cervical incompetence. She subsequently conceived with twins. She delivered spontaneously preterm at 28 weeks. Both children are alive and well. After 20 years of follow-up, she underwent a laparoscopic hysterectomy with no evidence of recurrence. She remains disease free.

Conclusion

Whilst radical completion surgery should be advised in UA, this case, in addition to all published conservatively managed cases of UA, demonstrates that conservative management is possible in appropriately selected women. Intensive monitoring post-operatively is essential owing to the risk of recurrence; however, this may pose deleterious side effects which require consideration.
Literature
1.
go back to reference Kanjeekal S, Chambers A, Fung NF, Verma S (2005) Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol 97:624–637CrossRef Kanjeekal S, Chambers A, Fung NF, Verma S (2005) Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol 97:624–637CrossRef
2.
go back to reference D'Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116(1):131–139CrossRef D'Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116(1):131–139CrossRef
3.
go back to reference Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynecol Obstet 104:177–178CrossRef Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynecol Obstet 104:177–178CrossRef
4.
go back to reference Bernard B, Clarke BA, Malowany JI, McAlpine J, Lee CH, Atenafu EG et al (2013) Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival. Gynecol Oncol 131(3):634–639CrossRef Bernard B, Clarke BA, Malowany JI, McAlpine J, Lee CH, Atenafu EG et al (2013) Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival. Gynecol Oncol 131(3):634–639CrossRef
5.
go back to reference Clement PB, Scully RE (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21:363–381CrossRef Clement PB, Scully RE (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21:363–381CrossRef
6.
go back to reference Arend R, Bagaria M, Lewin SN, Sun X, Deutsch I, Burke WM et al (2010) Long-term outcome and natural history of uterine adenosarcoma. Gynecol Oncol 119(2):305–308CrossRef Arend R, Bagaria M, Lewin SN, Sun X, Deutsch I, Burke WM et al (2010) Long-term outcome and natural history of uterine adenosarcoma. Gynecol Oncol 119(2):305–308CrossRef
7.
go back to reference Clement PB, Scully RE (1974) Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of distinctive type of mullerian mixed tumor. Cancer 34:1138–1149CrossRef Clement PB, Scully RE (1974) Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of distinctive type of mullerian mixed tumor. Cancer 34:1138–1149CrossRef
8.
go back to reference Abeler VM, Røyne O, Thoresen S, Danielsen HR, Nesland JM, Kristensen GB (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 women. Histopathology 54:355–364CrossRef Abeler VM, Røyne O, Thoresen S, Danielsen HR, Nesland JM, Kristensen GB (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 women. Histopathology 54:355–364CrossRef
9.
go back to reference Lee YJ, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT et al (2017) Feasibility of uterine preservation in the management of early-stage UAs: a single institute experience. World J Surg Oncol 15:87CrossRef Lee YJ, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT et al (2017) Feasibility of uterine preservation in the management of early-stage UAs: a single institute experience. World J Surg Oncol 15:87CrossRef
10.
go back to reference Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS (2001) Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 83(1):89–94CrossRef Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS (2001) Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 83(1):89–94CrossRef
11.
go back to reference Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM et al (2014) Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol 135:455–461CrossRef Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM et al (2014) Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol 135:455–461CrossRef
12.
go back to reference Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S et al (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer 24(9):S78–S82CrossRef Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S et al (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer 24(9):S78–S82CrossRef
13.
go back to reference Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P et al (2015) Sarcoma of the uterus. Guideline of the DGGG. Geburts Frauenheilk 75(10):1028–1042CrossRef Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P et al (2015) Sarcoma of the uterus. Guideline of the DGGG. Geburts Frauenheilk 75(10):1028–1042CrossRef
14.
go back to reference Tanner EJ, Toussaint T, Leitao MM, Hensley ML, Soslow RA, Gardener GJ et al (2013) Management of UAs with and without sarcomatous overgrowth. Gynecol Oncol 129:140–144CrossRef Tanner EJ, Toussaint T, Leitao MM, Hensley ML, Soslow RA, Gardener GJ et al (2013) Management of UAs with and without sarcomatous overgrowth. Gynecol Oncol 129:140–144CrossRef
15.
go back to reference Donnez J, Dolmans M (2013) Fertility preservation in women. Nature 9(12):735–749 Donnez J, Dolmans M (2013) Fertility preservation in women. Nature 9(12):735–749
16.
go back to reference Pathiraja P, Tozzi R (2013) Advances in gynaecological oncology surgery. Best Pract Res Clin Obstet Gynaecol 27(3):415–420CrossRef Pathiraja P, Tozzi R (2013) Advances in gynaecological oncology surgery. Best Pract Res Clin Obstet Gynaecol 27(3):415–420CrossRef
17.
go back to reference Kenny LC, Lavender T, McNamee R, O’Neill SM, Mills T, Khashan AS (2013) Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS ONE 8:e56583CrossRef Kenny LC, Lavender T, McNamee R, O’Neill SM, Mills T, Khashan AS (2013) Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS ONE 8:e56583CrossRef
18.
go back to reference Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF (1992) Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11:75–88CrossRef Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF (1992) Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11:75–88CrossRef
19.
go back to reference Goh C, Lin XH, Chin PS, Lim YK (2018) Uterine preservation in a young patient with adenosarcoma of the uterus: case report and review of literature. Gynecol Oncol Rep 25:27–29CrossRef Goh C, Lin XH, Chin PS, Lim YK (2018) Uterine preservation in a young patient with adenosarcoma of the uterus: case report and review of literature. Gynecol Oncol Rep 25:27–29CrossRef
20.
go back to reference Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V (2002) Risk factors in miscarriage: a review. Eur J Obstet Gynecol Reprod Biol 102:111–119CrossRef Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V (2002) Risk factors in miscarriage: a review. Eur J Obstet Gynecol Reprod Biol 102:111–119CrossRef
21.
go back to reference Sheinera E, Bashiria A, Shoham-Vardib I, Hershkovitz R, Mazor M (2004) Preterm deliveries among women with MacDonald cerclage performed due to cervical incompetence. Fetal Diagn Ther 19:361–365CrossRef Sheinera E, Bashiria A, Shoham-Vardib I, Hershkovitz R, Mazor M (2004) Preterm deliveries among women with MacDonald cerclage performed due to cervical incompetence. Fetal Diagn Ther 19:361–365CrossRef
22.
go back to reference Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O (2006) Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 85(6):700–705CrossRef Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O (2006) Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 85(6):700–705CrossRef
23.
go back to reference Watson LF, Rayner JA, King J, Jolley D, Forster D (2012) Intracervical procedures and the risk of subsequent very preterm birth: a case–control study. Acta Obstet Gynecol Scand 91:204–210CrossRef Watson LF, Rayner JA, King J, Jolley D, Forster D (2012) Intracervical procedures and the risk of subsequent very preterm birth: a case–control study. Acta Obstet Gynecol Scand 91:204–210CrossRef
24.
go back to reference Nasioudis D, Chapman-Davis E, Frey M, Holcomb K (2017) Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma. J Gynecol Oncol 28(4):e46CrossRef Nasioudis D, Chapman-Davis E, Frey M, Holcomb K (2017) Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma. J Gynecol Oncol 28(4):e46CrossRef
25.
go back to reference Lemmers M, Verschoor MAC, Hooker AB, Opmeer BC, Limpens J, Huirne JAF et al (2016) Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis. Human Reprod 31(1):34–44CrossRef Lemmers M, Verschoor MAC, Hooker AB, Opmeer BC, Limpens J, Huirne JAF et al (2016) Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis. Human Reprod 31(1):34–44CrossRef
26.
go back to reference Faubion SS, MacLaughlin KL, Long ME, Pruthi S, Casey PM (2015) Surveillance and care of the gynecologic cancer survivor. J Womens Health 24(11):899–906CrossRef Faubion SS, MacLaughlin KL, Long ME, Pruthi S, Casey PM (2015) Surveillance and care of the gynecologic cancer survivor. J Womens Health 24(11):899–906CrossRef
Metadata
Title
Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow-up
Authors
Ariadne L’Heveder
Benjamin P. Jones
Srdjan Saso
Jen Barcroft
Robert Richardson
Baljeet Kaur
Sadaf Ghaem-Maghami
Joseph Yazbek
J. Richard Smith
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 5/2019
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05306-6

Other articles of this Issue 5/2019

Archives of Gynecology and Obstetrics 5/2019 Go to the issue